This inventor holds 3 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2002-2003.
Location History:
- Göteborg, SE (2002 - 2003)
- Gothenburg, SE (2003)
Company Filing History:
Years Active: 2002-2003
Title: The Innovative Contributions of Inventor Catherine Boissier
Introduction
Catherine Boissier is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for producing drug particles. With a total of 3 patents to his name, Boissier's work has the potential to impact drug formulation and delivery.
Latest Patents
Catherine Boissier's latest patents include innovative methods that enhance the production of drug particles. One of his patents is titled "Method of producing drug particles," which describes a technique for preparing drug particles that are susceptible to degradation using a fluid gas technique. Another significant patent is "Method and device for forming particles," which outlines a method for forming particles of a substance by introducing a fluid gas and a vehicle system into a controlled mixing chamber. This invention emphasizes the importance of inducing turbulence to create a controlled disorder in the flow, thereby optimizing particle formation.
Career Highlights
Boissier is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative solutions in drug development, contributing to advancements in the pharmaceutical industry. His expertise in particle formation techniques is particularly valuable in the context of developing effective drug delivery systems.
Collaborations
Catherine Boissier has collaborated with several talented individuals in his field, including Anne Mari Juppo and Marie-Louise Andersson. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
Catherine Boissier's contributions to the field of pharmaceuticals through his innovative patents and work at AstraZeneca highlight his role as a key inventor in drug particle production. His advancements have the potential to significantly enhance drug formulation and delivery methods.